athenahealth Company Profile (NASDAQ:ATHN)

About athenahealth (NASDAQ:ATHN)

athenahealth logoathenahealth, Inc. provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet. The Company has a range of network-enabled services to support healthcare providers across the continuum of care. The Company offers various combinations of its services to its clients, including athenaOne and athenaOne for Hospitals and Health Systems, depending on whether they are medical groups and practices or hospitals and larger health systems. As of December 31, 2016, the Company connected care across a national network of approximately 88,000 providers and approximately 86 million patients. Its suite of network-enabled services includes athenaCollector, athenaClinicals, athenaCommunicator, athenaCoordinator, Population Health and Epocrates.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Software & Technology Services
  • Sub-Industry: Health Care Technology
  • Symbol: NASDAQ:ATHN
  • CUSIP: 04685W10
  • Web: www.athenahealth.com
Capitalization:
  • Market Cap: $6.18234 billion
  • Outstanding Shares: 39,834,000
Average Prices:
  • 50 Day Moving Avg: $142.47
  • 200 Day Moving Avg: $123.33
  • 52 Week Range: $90.11 - $156.84
P/E:
  • Trailing P/E Ratio: 193.43
  • Foreward P/E Ratio: 139.83
  • P/E Growth: 4.07
Sales & Book Value:
  • Annual Revenue: $1.15 billion
  • Price / Sales: 5.28
  • Book Value: $17.97 per share
  • Price / Book: 8.48
Profitability:
  • EBIDTA: $127.7 million
  • Net Margins: 2.80%
  • Return on Equity: 6.91%
  • Return on Assets: 3.80%
Debt:
  • Debt-to-Equity Ratio: 0.37%
  • Current Ratio: 1.62%
  • Quick Ratio: 1.62%
Misc:
  • Average Volume: 805,154 shs.
  • Beta: 1.79
  • Short Ratio: 14.67
 
Frequently Asked Questions for athenahealth (NASDAQ:ATHN)

What is athenahealth's stock symbol?

athenahealth trades on the NASDAQ under the ticker symbol "ATHN."

How were athenahealth's earnings last quarter?

athenahealth, Inc. (NASDAQ:ATHN) released its earnings results on Thursday, July, 20th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.12. The company earned $301.10 million during the quarter, compared to analyst estimates of $298.68 million. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. athenahealth's quarterly revenue was up 15.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.34 earnings per share. View athenahealth's Earnings History.

When will athenahealth make its next earnings announcement?

athenahealth is scheduled to release their next quarterly earnings announcement on Wednesday, October, 18th 2017. View Earnings Estimates for athenahealth.

Where is athenahealth's stock going? Where will athenahealth's stock price be in 2017?

23 brokerages have issued 1 year price targets for athenahealth's shares. Their forecasts range from $88.00 to $190.00. On average, they expect athenahealth's share price to reach $146.70 in the next year. View Analyst Ratings for athenahealth.

What are analysts saying about athenahealth stock?

Here are some recent quotes from research analysts about athenahealth stock:

  • 1. Cantor Fitzgerald analysts commented, "It is difficult to predict what the ultimate outcome will be given the Elliott stake. Over the years, ATHN has typically invested for longer-term growth, which has often resulted in inconsistent quarterly performance. After a bumpy roll-out of the streamlined platform last year, we believe performance has improved. Also, the company’s investment in the small hospital market is moving along better than we originally expected. We maintain our view that the company can help physician offices transition to value-based reimbursement and increase its population health offerings. It remains to be seen if athena can enhance the functionality of its hospital offering to move into larger hospitals. Still, athena continues to have a significant presence in the ambulatory market, and it should be able to better leverage its capabilities over time. Praxify Techologies acquisition reflects another long-term investment. On June 7, ATHN announced that it acquired privately-held Praxify Technologies for $63 million in cash. We characterize this acquisition as a technology acquisition which should help the company add app-layer technology to its ambulatory and inpatient products. We assume the acquisition will be dilutive in the near term but help the company’s long-term product performance. Basis for higher price target. With the filing by Elliott, we increased our DCF-based price target to $140." (6/13/2017)
  • 2. Piper Jaffray Companies analysts commented, "We have updated our model and estimates to reflect the new company presentation. We have slightly lowered our PT to $160 from $162 to reflect our revised estimates. Despite this we remain confident in the company's FY17 outlook, and would be buying shares at current market valuation. Reiterate OW, PT $160." (2/7/2017)
  • 3. Stifel Nicolaus analysts commented, "ATHN reported 4Q EPS after the close 2/2/17 with a call at 8am ET this morning. Revenue ($288.2mn) was 5% ($17mn) below consensus and guidance, while EPS of $0.62 exceeded consensus ($0.51). Management reiterated 2017 revenue, bookings and adjusted operating income guidance; however, with the revenue miss revenue growth must reaccelerate more than previously expected and margins must improve less." (2/6/2017)
  • 4. According to Zacks Investment Research, "We believe that athenahealth’s strong product portfolio, expanding physician base and unique business model will continue to drive the top line. The recognition of athenahealth as an Electronic Health Record (EHR) usability leader is also a significant positive, in our opinion. However, the company's second quarter 2016 results disappointed us, as it missed the Zacks Consenus Estimates on both the lines. The company's guidance also failed to impress us. We believe lack of enterprise-sized deals, winding up of government funded stimulus and increasing competition in the HCIT market are major headwinds, at least in the near term." (8/4/2016)

Who are some of athenahealth's key competitors?

Who are athenahealth's key executives?

athenahealth's management team includes the folowing people:

  • Jonathan S. Bush, Chairman of the Board, President, Chief Executive Officer
  • Karl Stubelis, Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
  • Stephen N. Kahane M.D., Executive Vice President ; President - Client Organisation
  • Prakash Khot, Senior Vice President, Chief Technology Officer
  • Timothy O'Brien, Senior Vice President, Chief Marketing Officer
  • Dan Haley, Senior Vice President, General Counsel, Secretary
  • Kyle Armbrester, Senior Vice President, Chief Product Officer
  • Brandon H. Hull, Lead Independent Director
  • Thomas J. Szkutak, Director
  • Amy Abernethy M.D. Ph.D., Independent Director

Who owns athenahealth stock?

athenahealth's stock is owned by many different of retail and institutional investors. Top institutional investors include JANUS HENDERSON GROUP PLC (14.60%), Riverbridge Partners LLC (2.60%), Sumitomo Mitsui Asset Management Company LTD (1.09%), ELLIOTT ASSOCIATES, L.P. (1.00%), Barton Investment Management (0.60%) and Peregrine Capital Management LLC (0.35%). Company insiders that own athenahealth stock include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, Ed Park, John A Kane, Jonathan Bush, Jonathan D Porter, Karl Stubelis, Kristi Ann Matus, Robert Cosinuke, Stephen N Kahane and Timothy John O'brien. View Institutional Ownership Trends for athenahealth.

Who sold athenahealth stock? Who is selling athenahealth stock?

athenahealth's stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Gagnon Securities LLC, Peregrine Capital Management LLC, Riverbridge Partners LLC, Gagnon Advisors LLC, Rockefeller Financial Services Inc., US Bancorp DE and Clear Harbor Asset Management LLC. Company insiders that have sold athenahealth stock in the last year include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, Ed Park, John A Kane, Jonathan Bush, Jonathan D Porter and Karl Stubelis. View Insider Buying and Selling for athenahealth.

Who bought athenahealth stock? Who is buying athenahealth stock?

athenahealth's stock was purchased by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Asset Management Company LTD, Barton Investment Management, Huntington National Bank, CrestPoint Capital Management LLC, Aperio Group LLC and Cribstone Capital Management LLC. View Insider Buying and Selling for athenahealth.

How do I buy athenahealth stock?

Shares of athenahealth can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is athenahealth's stock price today?

One share of athenahealth stock can currently be purchased for approximately $152.42.


MarketBeat Community Rating for athenahealth (NASDAQ ATHN)
Community Ranking:  2.3 out of 5 ( )
Outperform Votes:  435 (Vote Outperform)
Underperform Votes:  493 (Vote Underperform)
Total Votes:  928
MarketBeat's community ratings are surveys of what our community members think about athenahealth and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for athenahealth (NASDAQ:ATHN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 9 Hold Ratings, 12 Buy Ratings
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: $146.70 (3.75% downside)

Analysts' Ratings History for athenahealth (NASDAQ:ATHN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/24/2017Citigroup Inc.Reiterated RatingBuy$169.00 -> $186.00LowView Rating Details
7/24/2017Leerink SwannReiterated RatingMarket Perform -> Positive$140.00 -> $155.00LowView Rating Details
7/24/2017First AnalysisDowngradeEqual Weight -> Underweight$99.00 -> $125.00LowView Rating Details
7/22/2017Evercore ISIReiterated RatingOutperform$155.00 -> $163.00LowView Rating Details
7/22/2017Wells Fargo & CompanyReiterated RatingOutperform$130.00 -> $190.00LowView Rating Details
7/21/2017Oppenheimer Holdings, Inc.Boost Price TargetOutperform$154.00 -> $184.00MediumView Rating Details
7/21/2017Piper Jaffray CompaniesReiterated RatingOverweight$171.00HighView Rating Details
7/21/2017William BlairReiterated RatingMarket PerformMediumView Rating Details
7/19/2017J P Morgan Chase & CoSet Price TargetHold$136.00LowView Rating Details
7/17/2017SunTrust Banks, Inc.Reiterated RatingBuy$150.00LowView Rating Details
7/7/2017Dougherty & CoDowngradeBuy -> NeutralHighView Rating Details
7/7/2017ArgusInitiated CoverageHoldHighView Rating Details
6/26/2017Jefferies Group LLCReiterated RatingHold$135.00MediumView Rating Details
6/16/2017Stifel NicolausReiterated RatingHold$106.00 -> $151.00LowView Rating Details
6/13/2017Cantor FitzgeraldDowngradeOverweight -> Neutral$140.00LowView Rating Details
5/25/2017Robert W. BairdBoost Price TargetOutperform$140.00 -> $160.00LowView Rating Details
5/1/2017Barclays PLCSet Price TargetUnderweight$97.00 -> $88.00MediumView Rating Details
2/6/2017KeyCorpSet Price TargetBuy$140.00N/AView Rating Details
2/7/2017Berenberg BankInitiated CoverageBuy$143.00N/AView Rating Details
2/6/2017Canaccord GenuityReiterated RatingHold$112.00N/AView Rating Details
1/4/2017Pacific CrestUpgradeOverweight$140.00N/AView Rating Details
1/3/2017Royal Bank Of CanadaInitiated CoverageOutperformN/AView Rating Details
10/26/2016Morgan StanleyDowngradeOverweight -> Equal Weight$153.00 -> $117.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMarket Perform$145.00 -> $140.00N/AView Rating Details
7/22/2016Deutsche Bank AGDowngradeBuy -> Hold$165.00 -> $147.00N/AView Rating Details
2/8/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$155.00 -> $149.00N/AView Rating Details
2/8/2016Topeka Capital MarketsUpgradeHold -> Buy$169.00 -> $160.00N/AView Rating Details
2/5/2016Cowen and CompanyReiterated RatingOutperform$174.00 -> $162.00N/AView Rating Details
10/23/2015Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$160.00N/AView Rating Details
10/21/2015Avondale PartnersInitiated CoverageMarket Perform$175.00N/AView Rating Details
(Data available from 7/26/2015 forward)

Earnings

Earnings History for athenahealth (NASDAQ:ATHN)
Earnings by Quarter for athenahealth (NASDAQ:ATHN)
Earnings History by Quarter for athenahealth (NASDAQ ATHN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/18/2017$0.53N/AView Earnings Details
7/20/2017Q2 2017$0.39$0.51$298.68 million$301.10 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.11$0.10$296.49 million$285.40 millionViewN/AView Earnings Details
2/2/2017Q4 2016$0.51$0.62$303.72 million$288.20 millionViewListenView Earnings Details
10/20/2016Q3$0.47$0.60$280.17 million$276.67 millionViewListenView Earnings Details
7/21/2016Q2$0.42$0.34$274.07 million$261.90 millionViewListenView Earnings Details
4/28/2016Q1$0.26$0.34$248.49 million$256.15 millionViewListenView Earnings Details
2/4/2016Q415$0.41$0.45$257.68 million$257.50 millionViewN/AView Earnings Details
10/22/2015Q315$0.26$0.36$233.03 million$236.10 millionViewListenView Earnings Details
7/23/2015Q215$0.25$0.32$227.08 million$224.70 millionViewListenView Earnings Details
4/30/2015Q115($0.10)$0.24$205.24 million$206.40 millionViewListenView Earnings Details
2/5/2015Q414$0.39$0.58$207.99 million$213.20 millionViewN/AView Earnings Details
10/16/2014Q314$0.27$0.27$190.40 million$190.40 millionViewListenView Earnings Details
7/17/2014Q214$0.22$0.32$182.14 million$185.90 millionViewN/AView Earnings Details
4/17/2014Q114($0.01)$0.12$170.03 million$163.00 millionViewListenView Earnings Details
2/6/2014Q413$0.45$0.57$168.39 million$171.60 millionViewN/AView Earnings Details
10/17/2013Q313$0.31$0.29$154.80 million$151.50 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.22($0.08)$148.24 million$149.30 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.23$0.38$121.05 million$125.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.28$0.29$116.97 million$116.30 millionViewListenView Earnings Details
10/18/2012$0.26$0.30ViewN/AView Earnings Details
7/19/2012$0.23$0.24ViewN/AView Earnings Details
4/26/2012$0.17$0.17ViewN/AView Earnings Details
2/15/2012$0.23$0.26ViewN/AView Earnings Details
10/20/2011$0.20$0.24ViewN/AView Earnings Details
7/21/2011$0.19$0.22ViewN/AView Earnings Details
4/28/2011$0.13$0.17ViewN/AView Earnings Details
2/17/2011$0.20$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for athenahealth (NASDAQ:ATHN)
2017 EPS Consensus Estimate: $1.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.17$0.28$0.23
Q2 20172$0.06$0.34$0.20
Q3 20172$0.28$0.36$0.32
Q4 20172$0.41$0.50$0.46
(Data provided by Zacks Investment Research)

Dividends

Dividend History for athenahealth (NASDAQ:ATHN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for athenahealth (NASDAQ:ATHN)
Insider Ownership Percentage: 3.20%
Insider Trades by Quarter for athenahealth (NASDAQ:ATHN)
Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)
Insider Trades by Quarter for athenahealth (NASDAQ:ATHN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/21/2017Jonathan D. PorterSVPSell422$154.00$64,988.00View SEC Filing  
7/17/2017Jonathan D. PorterSVPSell300$143.13$42,939.00View SEC Filing  
7/3/2017Brandon H. HullDirectorSell800$140.81$112,648.00View SEC Filing  
7/3/2017Jonathan BushCEOSell4,000$140.52$562,080.00View SEC Filing  
6/15/2017Jonathan D. PorterSVPSell300$142.27$42,681.00View SEC Filing  
6/5/2017Karl StubelisCFOSell3,952$138.98$549,248.96View SEC Filing  
5/18/2017Bradford Kyle ArmbresterSVPSell2,431$130.00$316,030.00View SEC Filing  
5/18/2017Brandon H. HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
5/18/2017Jonathan BushCEOSell4,000$125.85$503,400.00View SEC Filing  
5/15/2017Jonathan D. PorterSVPSell300$109.48$32,844.00View SEC Filing  
4/25/2017Jonathan BushCEOSell8,000$120.00$960,000.00View SEC Filing  
1/27/2017John A KaneDirectorSell2,875$123.11$353,941.25View SEC Filing  
1/12/2017Jonathan BushCEOSell4,000$120.00$480,000.00View SEC Filing  
12/15/2016Amy AbernethyDirectorSell1,000$117.15$117,150.00View SEC Filing  
12/15/2016Ed ParkCOOSell2,500$117.15$292,875.00View SEC Filing  
12/15/2016Jonathan BushCEOSell8,000$120.00$960,000.00View SEC Filing  
12/1/2016Ed ParkCOOSell1,500$94.60$141,900.00View SEC Filing  
10/27/2016John A. KaneDirectorSell5,750$122.63$705,122.50View SEC Filing  
10/10/2016Bradford Kyle ArmbresterSVPSell2,545$130.00$330,850.00View SEC Filing  
10/10/2016Brandon H HullDirectorSell2,400$130.00$312,000.00View SEC Filing  
10/3/2016Daniel P HaleySVPSell2,109$124.43$262,422.87View SEC Filing  
10/3/2016Jonathan BushCEOSell4,000$124.34$497,360.00View SEC Filing  
9/7/2016Karl StubelisVPSell928$123.36$114,478.08View SEC Filing  
8/15/2016Ed ParkCOOSell4,000$124.20$496,800.00View SEC Filing  
8/1/2016Jonathan BushCEOSell4,000$128.19$512,760.00View SEC Filing  
7/27/2016John A KaneDirectorSell2,875$128.81$370,328.75View SEC Filing  
7/6/2016Ed ParkCOOSell1,500$136.85$205,275.00View SEC Filing  
7/1/2016Brandon H HullDirectorSell800$137.48$109,984.00View SEC Filing  
7/1/2016Jonathan BushCEOSell4,000$138.21$552,840.00View SEC Filing  
6/2/2016Brandon H HullDirectorSell800$130.00$104,000.00View SEC Filing  
6/1/2016Ed ParkCOOSell1,500$125.82$188,730.00View SEC Filing  
6/1/2016Jonathan BushCEOSell4,000$125.97$503,880.00View SEC Filing  
5/4/2016Ed ParkCOOSell1,500$127.81$191,715.00View SEC Filing  
5/2/2016Brandon H HullDirectorSell800$132.74$106,192.00View SEC Filing  
5/2/2016Jonathan BushCEOSell4,000$132.09$528,360.00View SEC Filing  
5/2/2016Kristi Ann MatusEVPSell415$133.27$55,307.05View SEC Filing  
4/25/2016Karl StubelisVPSell547$138.64$75,836.08View SEC Filing  
4/6/2016Ed ParkCOOSell1,500$139.15$208,725.00View SEC Filing  
4/1/2016Brandon H HullDirectorSell800$137.72$110,176.00View SEC Filing  
4/1/2016Jonathan BushCEOSell4,000$138.44$553,760.00View SEC Filing  
4/1/2016Kristi Ann MatusEVPSell415$138.61$57,523.15View SEC Filing  
3/3/2016Bradford Kyle ArmbresterSVPSell1,369$132.04$180,762.76View SEC Filing  
3/1/2016Brandon H HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
3/1/2016Daniel P HaleySVPSell1,279$130.64$167,088.56View SEC Filing  
3/1/2016Ed ParkCOOSell1,500$131.66$197,490.00View SEC Filing  
3/1/2016Jonathan BushCEOSell4,000$129.61$518,440.00View SEC Filing  
3/1/2016Kristi Ann MatusEVPSell415$129.53$53,754.95View SEC Filing  
3/1/2016Timothy John O'brienCMOSell846$132.25$111,883.50View SEC Filing  
2/16/2016Bradford Kyle ArmbresterSVPSell1,657$127.11$210,621.27View SEC Filing  
2/16/2016Timothy John O'brienCMOSell816$127.08$103,697.28View SEC Filing  
2/3/2016Ed ParkCOOSell1,500$140.61$210,915.00View SEC Filing  
2/1/2016Jonathan BushCEOSell4,000$140.14$560,560.00View SEC Filing  
2/1/2016Kristi Ann MatusEVPSell415$141.08$58,548.20View SEC Filing  
1/27/2016John A. KaneDirectorSell2,875$140.81$404,828.75View SEC Filing  
1/6/2016Ed ParkCOOSell1,500$161.89$242,835.00View SEC Filing  
1/4/2016Jonathan BushCEOSell4,000$156.79$627,160.00View SEC Filing  
1/4/2016Kristi Ann MatusEVPSell415$159.06$66,009.90View SEC Filing  
12/2/2015Ed ParkCOOSell1,500$166.81$250,215.00View SEC Filing  
11/20/2015Stephen N KahaneEVPSell1,280$157.80$201,984.00View SEC Filing  
11/6/2015Stephen N KahaneEVPSell5,000$159.51$797,550.00View SEC Filing  
11/4/2015Ed ParkCOOSell1,500$162.32$243,480.00View SEC Filing  
11/3/2015Jonathan BushCEOSell14,750$156.50$2,308,375.00View SEC Filing  
10/27/2015John A. KaneDirectorSell2,875$150.44$432,515.00View SEC Filing  
10/23/2015Jonathan BushCEOSell20,000$157.50$3,150,000.00View SEC Filing  
10/23/2015Robert CosinukeCMOSell1,211$159.02$192,573.22View SEC Filing  
10/23/2015Stephen N KahaneEVPSell5,000$150.50$752,500.00View SEC Filing  
10/20/2015Stephen N KahaneEVPSell2,000$132.88$265,760.00View SEC Filing  
10/7/2015Ed ParkCOOSell1,500$134.23$201,345.00View SEC Filing  
10/2/2015Jonathan BushCEOSell1,000$130.74$130,740.00View SEC Filing  
9/15/2015Stephen N KahaneEVPSell2,000$135.77$271,540.00View SEC Filing  
9/2/2015Ed ParkCOOSell1,500$129.64$194,460.00View SEC Filing  
9/2/2015Jonathan BushCEOSell1,000$131.09$131,090.00View SEC Filing  
8/18/2015Stephen N KahaneEVPSell2,000$141.49$282,980.00View SEC Filing  
7/24/2015David Eric RobinsonDirectorSell10,000$130.00$1,300,000.00View SEC Filing  
7/21/2015Stephen N KahaneEVPSell2,000$117.32$234,640.00View SEC Filing  
7/2/2015Jonathan BushCEOSell1,000$114.17$114,170.00View SEC Filing  
6/2/2015Jonathan BushCEOSell1,000$115.32$115,320.00View SEC Filing  
4/27/2015John A KaneDirectorSell2,875$125.35$360,381.25View SEC Filing  
4/14/2015Karl StubelisVPSell1,115$126.28$140,802.20View SEC Filing  
4/2/2015Jonathan BushCEOSell1,000$118.77$118,770.00View SEC Filing  
3/10/2015James L MannDirectorSell13,106$121.27$1,589,364.62View SEC Filing  
3/3/2015Robert CosinukeCMOSell6,000$128.15$768,900.00View SEC Filing  
2/24/2015Jonathan BushCEOSell2,499$130.23$325,444.77View SEC Filing  
2/18/2015Jonathan BushCEOSell2,498$132.04$329,835.92View SEC Filing  
2/10/2015Jonathan BushCEOSell7,495$135.82$1,017,970.90View SEC Filing  
2/5/2015David Eric RobinsonDirectorSell25,000$143.17$3,579,250.00View SEC Filing  
2/3/2015Robert CosinukeCMOSell6,000$139.06$834,360.00View SEC Filing  
1/5/2015David Eric RobinsonDirectorSell25,000$145.14$3,628,500.00View SEC Filing  
1/5/2015Robert CosinukeCMOSell6,000$145.18$871,080.00View SEC Filing  
12/22/2014Robert CosinukeCMOSell6,000$139.32$835,920.00View SEC Filing  
12/2/2014Jonathan BushCEOSell1,000$116.55$116,550.00View SEC Filing  
10/10/2014Robert CosinukeCMOSell3,000$123.78$371,340.00View SEC Filing  
10/2/2014Jonathan BushCEOSell1,000$128.41$128,410.00View SEC Filing  
9/10/2014Robert CosinukeCMOSell6,000$138.08$828,480.00View SEC Filing  
8/11/2014Robert CosinukeCMOSell6,000$129.43$776,580.00View SEC Filing  
8/4/2014Jonathan BushCEOSell1,000$121.58$121,580.00View SEC Filing  
7/10/2014Robert CosinukeCMOSell6,000$120.10$720,600.00View SEC Filing  
7/2/2014Jonathan BushCEOSell1,000$129.45$129,450.00View SEC Filing  
7/1/2014Stephen N KahaneInsiderSell5,000$127.60$638,000.00View SEC Filing  
6/12/2014David Eric RobinsonDirectorSell30,000$124.12$3,723,600.00View SEC Filing  
6/10/2014Robert CosinukeCMOSell6,000$125.07$750,420.00View SEC Filing  
6/2/2014Jonathan BushCEOSell1,000$125.82$125,820.00View SEC Filing  
6/2/2014Stephen N KahaneInsiderSell5,000$126.42$632,100.00View SEC Filing  
5/2/2014Jonathan BushCEOSell1,000$123.21$123,210.00View SEC Filing  
5/1/2014Stephen KahaneInsiderSell5,000$121.96$609,800.00View SEC Filing  
4/16/2014Stephen KahaneInsiderSell10,000$143.96$1,439,600.00View SEC Filing  
4/14/2014David Eric RobinsonDirectorSell60,000$140.61$8,436,600.00View SEC Filing  
4/10/2014Robert CosinukeCMOSell6,000$151.14$906,840.00View SEC Filing  
4/2/2014Jonathan BushCEOSell1,000$161.74$161,740.00View SEC Filing  
3/10/2014Robert CosinukeCMOSell6,000$181.60$1,089,600.00View SEC Filing  
2/18/2014Timothy AdamsCFOSell30,000$194.58$5,837,400.00View SEC Filing  
2/12/2014Dev IttycheriaDirectorSell2,000$181.17$362,340.00View SEC Filing  
2/10/2014Robert CosinukeCMOSell6,000$172.72$1,036,320.00View SEC Filing  
2/3/2014Daniel OrensteinSVPSell1,000$146.73$146,730.00View SEC Filing  
2/3/2014David Eric RobinsonDirectorSell4,000$146.86$587,440.00View SEC Filing  
1/10/2014Robert CosinukeCMOSell6,000$132.92$797,520.00View SEC Filing  
1/3/2014David Eric RobinsonDirectorSell4,000$131.86$527,440.00View SEC Filing  
12/10/2013Robert CosinukeCMOSell6,000$132.77$796,620.00View SEC Filing  
12/3/2013David Eric RobinsonDirectorSell4,000$132.48$529,920.00View SEC Filing  
12/2/2013Jonathan BushCEOSell1,000$132.24$132,240.00View SEC Filing  
11/4/2013David Eric RobinsonDirectorSell4,000$137.26$549,040.00View SEC Filing  
11/4/2013Jonathan BushCEOSell1,000$137.26$137,260.00View SEC Filing  
11/1/2013Daniel H OrensteinSVPSell1,000$133.15$133,150.00View SEC Filing  
10/21/2013Timothy M AdamsCFOSell20,000$138.39$2,767,800.00View SEC Filing  
10/18/2013Ed ParkCOOSell10,021$123.36$1,236,190.56View SEC Filing  
10/18/2013Jonathan BushCEOSell20,000$120.00$2,400,000.00View SEC Filing  
10/10/2013Robert CosinukeCMOSell6,000$108.21$649,260.00View SEC Filing  
10/3/2013David Eric RobinsonDirectorSell4,000$111.01$444,040.00View SEC Filing  
10/2/2013Jonathan BushCEOSell1,000$110.16$110,160.00View SEC Filing  
9/10/2013Robert CosinukeCMOSell6,000$109.68$658,080.00View SEC Filing  
9/3/2013Daniel OrensteinSVPSell1,000$106.73$106,730.00View SEC Filing  
9/3/2013David Eric RobinsonDirectorSell4,000$106.53$426,120.00View SEC Filing  
9/3/2013Jonathan BushCEOSell22,105$106.45$2,353,077.25View SEC Filing  
8/19/2013John KaneDirectorSell2,000$111.23$222,460.00View SEC Filing  
8/15/2013John KaneDirectorSell5,000$110.03$550,150.00View SEC Filing  
8/12/2013Robert CosinukeCMOSell6,000$115.72$694,320.00View SEC Filing  
8/5/2013David Eric RobinsonDirectorSell4,000$114.01$456,040.00View SEC Filing  
8/1/2013Daniel H OrensteinSVPSell1,000$113.73$113,730.00View SEC Filing  
8/1/2013Jonathan BushCEOSell5,000$113.94$569,700.00View SEC Filing  
7/12/2013Timothy M AdamsCFOSell10,000$106.14$1,061,400.00View SEC Filing  
7/11/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
7/10/2013Robert CosinukeCMOSell6,000$87.06$522,360.00View SEC Filing  
7/1/2013Daniel H OrensteinSVPSell1,000$85.01$85,010.00View SEC Filing  
7/1/2013Jonathan BushCEOSell5,000$85.39$426,950.00View SEC Filing  
6/17/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
6/10/2013Robert CosinukeCMOSell6,000$85.74$514,440.00View SEC Filing  
6/3/2013Daniel H OrensteinSVPSell1,000$84.22$84,220.00View SEC Filing  
6/3/2013Jonathan BushCEOSell5,000$84.39$421,950.00View SEC Filing  
5/10/2013Robert CosinukeCMOSell6,000$84.80$508,800.00View SEC Filing  
5/1/2013Jonathan BushCEOSell5,000$95.70$478,500.00View SEC Filing  
2/26/2013David Eric RobinsonDirectorSell10,000$90.13$901,300.00View SEC Filing  
8/10/2012Robert CosinukeCMOSell3,000$92.35$277,050.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for athenahealth (NASDAQ:ATHN)
Latest Headlines for athenahealth (NASDAQ:ATHN)
Source:
DateHeadline
americanbankingnews.com logoathenahealth (NASDAQ:ATHN) and Castlight Health, inc. (CSLT) Critical Analysis
www.americanbankingnews.com - July 25 at 4:25 PM
americanbankingnews.com logoathenahealth, Inc. (NASDAQ:ATHN) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - July 25 at 12:53 PM
americanbankingnews.com logoathenahealth, Inc. (NASDAQ:ATHN) Given Buy Rating at Citigroup Inc.
www.americanbankingnews.com - July 24 at 7:14 PM
rttnews.com logoAthenahealth Inc. (ATHN) Leaped To A New High On Strong Q2 Earnings
www.rttnews.com - July 24 at 12:56 PM
finance.yahoo.com logoEdited Transcript of ATHN earnings conference call or presentation 21-Jul-17 12:00pm GMT
finance.yahoo.com - July 24 at 12:56 PM
finance.yahoo.com logoThree takeaways on athenahealth's 'metamorphosis'
finance.yahoo.com - July 24 at 12:56 PM
americanbankingnews.com logoathenahealth, Inc. (ATHN) Receives Positive Rating from Leerink Swann
www.americanbankingnews.com - July 24 at 10:07 AM
americanbankingnews.com logoathenahealth, Inc. (ATHN) Earns "Positive" Rating from UBS AG
www.americanbankingnews.com - July 24 at 9:32 AM
americanbankingnews.com logoathenahealth, Inc. (ATHN) Raised to B- at TheStreet
www.americanbankingnews.com - July 23 at 9:26 PM
americanbankingnews.com logoathenahealth, Inc. (ATHN) Lifted to Hold at BidaskClub
www.americanbankingnews.com - July 23 at 7:28 PM
seekingalpha.com logoAthenahealth - Beauty Is In The Eye Of The Beholder - Seeking Alpha
seekingalpha.com - July 23 at 3:52 PM
americanbankingnews.com logoEvercore ISI Reaffirms "Outperform" Rating for athenahealth, Inc. (ATHN)
www.americanbankingnews.com - July 22 at 10:04 PM
americanbankingnews.com logoathenahealth, Inc. (ATHN) Given Outperform Rating at Wells Fargo & Company
www.americanbankingnews.com - July 22 at 7:34 PM
nasdaq.com logoAthenahealth Inc. (ATHN) Has Jumped To A New High After Q2 Profit Beat - Nasdaq
www.nasdaq.com - July 21 at 10:38 PM
americanbankingnews.com logoInsider Selling: athenahealth, Inc. (ATHN) SVP Sells 422 Shares of Stock
www.americanbankingnews.com - July 21 at 7:51 PM
americanbankingnews.com logoathenahealth, Inc. (NASDAQ:ATHN) Given Overweight Rating at Piper Jaffray Companies
www.americanbankingnews.com - July 21 at 7:16 PM
seekingalpha.com logoathenahealth's (ATHN) CEO Jonathan Bush on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 21 at 5:35 PM
finance.yahoo.com logoathenahealth, Inc. :ATHN-US: Earnings Analysis: Q2, 2017 By the Numbers : July 21, 2017
finance.yahoo.com - July 21 at 5:35 PM
finance.yahoo.com logoAthenahealth CEO: Metamorphosis is hard and good for us
finance.yahoo.com - July 21 at 5:35 PM
finance.yahoo.com logoWhy Plug Power, Capital One Financial, and athenahealth Jumped Today
finance.yahoo.com - July 21 at 5:35 PM
americanbankingnews.com logoOppenheimer Holdings, Inc. Increases athenahealth, Inc. (NASDAQ:ATHN) Price Target to $184.00
www.americanbankingnews.com - July 21 at 3:00 PM
americanbankingnews.com logoathenahealth, Inc. (NASDAQ:ATHN) Given Market Perform Rating at William Blair
www.americanbankingnews.com - July 21 at 11:22 AM
finance.yahoo.com logoShares of Activist Target AthenaHealth Soar After Second Quarter Results
finance.yahoo.com - July 20 at 10:38 PM
americanbankingnews.com logoathenahealth, Inc. (ATHN) Issues Earnings Results, Beats Expectations By $0.12 EPS
www.americanbankingnews.com - July 20 at 9:05 PM
fool.com logoathenahealth, Inc. Revenue Growth Accelerated in Second Quarter
www.fool.com - July 20 at 7:05 PM
nasdaq.com logoAfter-Hours Earnings Report for July 20, 2017 : MSFT, V, EBAY, COF, ISRG, SWKS, MXIM, CTAS, ETFC, PBCT, ATHN ... - Nasdaq
www.nasdaq.com - July 20 at 5:36 PM
nasdaq.com logoNotable Thursday Option Activity: GILD, GS, ATHN - Nasdaq
www.nasdaq.com - July 20 at 5:36 PM
globenewswire.com logoathenahealth, Inc. Reports Second Quarter Fiscal Year 2017 Results - GlobeNewswire (press release)
globenewswire.com - July 20 at 5:36 PM
finance.yahoo.com logoathenahealth, Inc. Reports Second Quarter Fiscal Year 2017 Results
finance.yahoo.com - July 20 at 5:35 PM
finance.yahoo.com logoAthenahealth beats Street 2Q forecasts
finance.yahoo.com - July 20 at 5:35 PM
finance.yahoo.com logoAthenahealth beats on top line
finance.yahoo.com - July 20 at 5:35 PM
seekingalpha.com logoathenahealth Q2 revenues up 15%; earnings up 621%; shares up 6% after hours
seekingalpha.com - July 20 at 4:53 PM
americanbankingnews.com logoHead to Head Contrast: athenahealth (NASDAQ:ATHN) & Castlight Health, inc. (CSLT)
www.americanbankingnews.com - July 20 at 12:42 PM
americanbankingnews.com logoathenahealth, Inc. (NASDAQ:ATHN) SVP Sells $42,939.00 in Stock
www.americanbankingnews.com - July 19 at 10:14 PM
nasdaq.com logoWhat's in Store for athenahealth (ATHN) in Q2 Earnings? - Nasdaq
www.nasdaq.com - July 19 at 5:22 PM
americanbankingnews.com logoathenahealth, Inc. (ATHN) Price Target Raised to $136.00
www.americanbankingnews.com - July 19 at 1:14 PM
finance.yahoo.com logoWhat's in Store for athenahealth (ATHN) in Q2 Earnings?
finance.yahoo.com - July 18 at 10:39 PM
streetinsider.com logoFollowing Athenahealth (ATHN) CFO Depature Suntrust Keeps $150 Price Target - StreetInsider.com
www.streetinsider.com - July 17 at 4:25 PM
globenewswire.com logoathenahealth Announces Chief Financial Officer Transition - GlobeNewswire (press release)
globenewswire.com - July 16 at 6:05 AM
americanbankingnews.com logoathenahealth, Inc. (NASDAQ:ATHN) Rating Reiterated by Piper Jaffray Companies
www.americanbankingnews.com - July 15 at 8:50 AM
americanbankingnews.com logo$298.48 Million in Sales Expected for athenahealth, Inc. (ATHN) This Quarter
www.americanbankingnews.com - July 15 at 8:19 AM
streetinsider.com logoathenahealth (ATHN) Announces CFO Transition; Reaffirms FY17 Guidance - StreetInsider.com
www.streetinsider.com - July 14 at 11:01 PM
baystreet.ca logoCanadian Inflation Figures Due Next Week
www.baystreet.ca - July 14 at 6:00 PM
streetinsider.com logoathenahealth (ATHN) Announces CFO Transition; Reaffirms FY17 Guidance
www.streetinsider.com - July 14 at 6:00 PM
finance.yahoo.com logoathenahealth Announces Chief Financial Officer Transition
finance.yahoo.com - July 14 at 5:59 PM
finance.yahoo.com logoAthenahealth losing its chief financial officer
finance.yahoo.com - July 14 at 5:59 PM
americanbankingnews.com logoathenahealth, Inc (NASDAQ:ATHN) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - July 13 at 10:08 PM
americanbankingnews.com logo$0.07 Earnings Per Share Expected for athenahealth, Inc. (NASDAQ:ATHN) This Quarter
www.americanbankingnews.com - July 13 at 2:16 PM
americanbankingnews.com logoCitigroup Inc. Reiterates Buy Rating for athenahealth, Inc. (ATHN)
www.americanbankingnews.com - July 10 at 3:04 PM
americanbankingnews.com logoathenahealth, Inc. (ATHN) Downgraded by Dougherty & Co to "Neutral"
www.americanbankingnews.com - July 7 at 11:48 AM

Social

Chart

athenahealth (ATHN) Chart for Wednesday, July, 26, 2017

This page was last updated on 7/26/2017 by MarketBeat.com Staff